A comprehensive preclinical evaluation was conducted to assess the efficacy and safety profile of tirzepatide 10mg in a model Tirzepatide 20mg (R&D Only) of [Target Disease]. Utilizing both in vitro and in vivo assays, researchers investigated the drug's ability to influence key pathways involved in the pathogenesis of the disease. Favorable result